High incidence of malaria in alpha-thalassaemic children.
The alpha+-thalassaemias are the commonest known human genetic disorders, affecting up to 80 per cent of some populations. Although there is good evidence from both epidemiological and clinical studies that these gene frequencies reflect selection by, and protection from, malaria, the mechanism is unknown. We have studied the epidemiology of malaria in childhood on the southwestern Pacific island of Espiritu Santo in Vanuatu and here we report that, paradoxically, both the incidence of uncomplicated malaria and the prevalence of splenomegaly, an index of malaria infection, are significantly higher in young children with alpha+-thalassaemia than in normal children. Furthermore, this effect is most marked in the youngest children and for the non-lethal parasite Plasmodium vivax. The alpha+-thalassaemias may have been selected for their ability beneficially to increase susceptibility to P. vivax, which, by acting as a natural vaccine in this community, induces limited cross-species protection against subsequent severe P. falciparum malaria.
Williams
T N
TN
Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK.
Maitland
K
K
Bennett
S
S
Ganczakowski
M
M
Peto
T E
TE
Newbold
C I
CI
Bowden
D K
DK
Weatherall
D J
DJ
Clegg
J B
JB
D000818:Animals; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007109:Immunity; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000150:complications* / Q000453:epidemiology* / Q000276:immunology; D016778:Malaria, Falciparum / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D016780:Malaria, Vivax / Q000276:immunology; D010966:Plasmodium vivax; D015995:Prevalence; D011446:Prospective Studies; D012641:Selection, Genetic; D013163:Splenomegaly / Q000453:epidemiology / Q000209:etiology; D009514:Vanuatu / Q000453:epidemiology; D017085:alpha-Thalassemia / Q000150:complications* / Q000453:epidemiology / Q000235:genetics